SlideShare a Scribd company logo
1 of 27
Ferritin=24 protein subunits capable of storing up to 4500 iron
atoms.
• Serum glycosylated ferritin: 60–80% (from macrophages)
• Non-glycosylated ferritin: 20–40% (from cell lysis)
• Serum ferritin: body iron stores, erythrocyte morphology. Hyperferritinemia can be a result
of inflammation, infection, chronic iron overload, or other uncommon pathologies
(hemophagocytic lymphohistiocytosis HLH) →Elevated serum ferritin concentrations are
common in clinical practice, marker of cellular damage and inflammation (hydroxyl
radical formation, oxidative stress), cell signaling and immune function, positively
associated with insulin resistance and the metabolic syndrome, correlated strongly
(r=0.49) with QT/QTs interval prolongation (longer than 450 ms). Hereditary
hemochromatosis (HH) is the most common genetic iron overload disorder among
Caucasians.
• 1865: Dr. Armand Trousseau described diabetes with bronze-colored skin.
• 1996: Feder et al. identified responsible gene named HFE (chromosomal location: 6p21).
• After the discovery of HFE, researchers discovered several other gene mutations that also
cause different types of HH.
• Symptoms of iron overload: fatigue, bronze-colored skin, abdominal pain, joint pain,
irregular menstruation, infertility, impotence, irregular heart rhythm, heart failure, new-onset
diabetes, difficulty controlling established diabetes, liver enzyme elevation, cirrhosis,
hepatocellular carcinoma, neurodegenerative disorders (Alzheimer, Parkinson, and
Huntington diseases).
• The central regulator of systemic iron homeostasis is hepcidin, a peptide hormone mainly
produced by hepatocytes.
Increased apoferritin/L
ferritin synthesis/secretion:
• Chronic ethanol ingestion
• Malignancy (malignant
histiocytosis; carcinomas of
lung, breast, ovary, kidney
lymphoma; liposarcoma)
• Gaucher disease
• Reactive histiocytosis.
• Hereditary hyperferritinemia-
cataract syndrome.
Increased ferritin release
from injured cells:
• Hepatic steatosis and
steatohepatitis
• Metabolic syndrome
(obesity, type 2 diabetes,
dyslipidemia,
hypertension)
• Chronic viral hepatitis
• Massive liver necrosis due
to sepsis/acute hepatitis/
toxic injury/ autoimmune
disorders
• Acute or chronic
infection/inflammation
• Acute myocardial infarction
• Splenic infarct
Increased ferritin
synthesis due to iron
overload:
• HFE and other types of
hemochromatosis
• Heritable & acquired
anemias associated with
ineffective erythropoiesis
• Increased iron absorption
from supplemental iron /
traditional beer
• transfusion iron overload
• Aceruloplasminemia
Renal failure
More than 40% of patients with
hyperferritinemia have several
causes simultaneously present.
• Genetic Iron Overload: 6 types:
• (1) Type 1 hemochromatosis – HFE hemochromatosis.
• (2) Type 2 hemochromatosis – juvenile hemochromatosis: (a) type 2A – mutation in
hemojuvelin gene; (b) type 2B – mutation in hepcidin gene.
• (3) Type 3 hemochromatosis – transferrin receptor 2 hemochromatosis.
• (4) Type 4 hemochromatosis – ferroportin disease: (a) type 4A – with low transferrin
saturation; (b) type 4B – with high transferrin saturation.
• (5) A(hypo)transferrinemia.
• (6) Aceruloplasminemia.
• Acquired Iron Overload:
• (1) Iatrogenic: (a) multiple blood transfusions; (b) parenteral iron therapy; (c) oral iron
therapy.
• (2) Chronic liver disease: (a) alcoholic liver disease; (b) hepatitis B and C; (c)
porphyria cutanea tarda.
• (3) Anemias: (a) thalassemia major; (b) chronic hemolytic anemia; (c) pyruvate kinase
deficiency.
• (4)
• Male 22 years old
• BMI=24
• BP= 112/77 mmHg, HR=75
bpm
• Lose 3kg/2 months
• No smoking, no alcohol
abuse.
• Family history : nothing
abnormal
.
• Objectives: evaluate serum Ferritin in diabetic patients to estimate prognosis, glucose control ability
• Methods: Descriptive cross-section statistics
• Test: CBC, FBS, HbA1C, LDLC-C, TG, AST, ALT, GGT, eGFR, Urinalysis, microalbuminuria, uric acid, HBsAg,
AntiHBs, AntiHBctotal, AntiHCV, FT4, TSH, Ferritin, serum iron, Transferin saturation, hsCRP, serum ionogram,
Antinuclear Antibody (ANA)
• Assess body mass index, blood pressure, liver steatosis (CAP: dB/m), liver fibrosis (Elastography: kPa)
(Fibroscan 502TOUCHE F60084), B mode transabdominal US (Operators: Bùi Hồng Lĩnh et al.).
• Inclusive criteria:
• DM patients > 17 yrs and euthyroid.
• Exclusive criteria
• Haematologic diseases: thalassemia, chronic hemolytic anemia, sickle cell diseases & myelodysplastic syndrome .
• Consumption beer / alcohol >20g/day
• HBV, HCV
• Malignancy.
• Drug induced hepatitis
• Autoimmune hepatitis
• Pregnancy, breast-feeding period.
• Iron supplement.
Staging liver steatosis and
fibrosis
• Steatosis severity: CAP: dB/m
• S0 = no steatosis
• S1 =normal steatosis
• S2 = mild steatosis
• S3 = moderate steatosis
• S4 = severe steatosis
• Stages of liver fibrosis: kPa
• F0 = no fibrosis
• F1 = mild fibrosis
• F2 = moderate fibrosis
• F3 = much fibrosis
• F4 = severe fibrosis
Classification (Asian) BMI ( kilogram/m 2 ) Results (patients) %
Underweight <18.5 5 1.86
Normal weight 18.5-24.9 150 55.97
Overweight 25-29.9 92 34.32
Obesity Class 1 30-34.9 19 7.08
Obesity Class 2 35-39.9 2 0.74
Extreme Obesity Class 3 >40 0 0
268
Hepatitis Non-hepatitis Total
Hyperferritinemia 101 22 133
Normal ferritinemia 76 69 145
177 91 268
Liver fibrosis & steatosis
S1 S2 S3 S4 Total
F0 52 14 12 7 85
F1 31 14 16 27 88
F2 18 4 3 11 36
F3 6 3 8 15 32
F4 11 4 5 7 27
Total 118 39 44 67 268
ESTIMATE OF HYPERFERRITINEMIA№ patients № patients of
hyperferritinemia
% patients of
hyperferrtinemia
F0 85 41 48,23 %
F1 88 45 51,13 %
F2 36 21 58,33 %
F3 32 15 46,57 %
F4 27 11 40,74 %
Total 268 133 49,62 %
№ patients № patients of
hyperferritinemia
% patients of
hyperferritinemia
S1 118 49 41.52 %
S2 39 18 46.15%
S3 44 26 59.09%
S4 67 40 59.70%
Total 268 133 49,62 %
• Sept 2018 - April 2019.
• 268 type 2 diabetic patients (119 M, 149F).
• Age=17 - 87 years .
• Duration of acquired DM= first onset - 23years.
• 21 obese patients (7.82%) + 92 overweight patients (34.32%) = 42.14%
• Hypertension: 152 patients (56,71%).
• Kidney disease: 87 patients (32.46%)..
• Dyslipidemia: 247 patients (92,16%).
• Liver steatosis: 150 patients (55.97%)
• Significant liver fibrosis (≥ F2: 35.45%)
• Hyperferritinemia: 133 patients (49,62%), no significant difference between liver fibrosis
degree.
• Young onset <40y: 38 patients (10.1%): 19 patients had hyperferritinemia (50%) → No
difference in frequency of hyperferritinemia between ages.
• Male hyperferritinemia:73 patients (73/119=61.3% male),
Female hyperferritinemia: 60 patients (60/149=40.2% female)
→
• Moderate & severe liver steatosis link to higher rate of hyperferritinemia (59% vs 41%).
• Hepatitis: 177 patients (66%); 101 hyperferritinemia hepatitic patients (57.06%)
No hepatitis: 91 patients (33.95%); 22 hyperferrtinemia patients (24.17%)
→
• Severe hyperferritinemia (Ferritinemia > 1000ng/mL: 18 cases)+ extreme hyperferritnemia
(Ferritinemia > 2000ng/mL: 4cases): 16.54% of hyperferritinemia
Hyperferritinemia:
-90% non-iron overload
-10%: iron overload
Discussion
• Dysmetabolic hyperferritinemia, being more prevalent especially in the presence of
metabolic syndrome, should be considered as the most likely disorder in such
scenarios of high ferritin with normal transferrin saturation.
• There are many types of hyperferritinemia presented in primary care.“
which are
more prevalent in the Gulf countries states, reaching up Arab 29% to 33% in
males, and 38% to 41% in females respectively.
• This study:
• Mild elevations of SF < 1000 μg/L are tolerable levels in the absence of HH; the
risk of hepatic iron overload is exceedingly low, whereas high elevation of SF >
1000μg/L requires specialist review to rule out HH with an increased risk of hepatic
iron overload, which leads to hepatic fibrosis and cirrhosis.
• International regulatory clearance and approvals (USA, Europe,
Australia)
• The technique is robust, there is no shift in accuracy or precision
across different MRI scanners, between MRI centres and models of
scanner.
• FerriScan is unaffected by inflammation, fibrosis, cirrhosis or
chelation therapy.
• FerriScan requires no breath-hold and may therefore be used for
paediatric patients, patients of all ages.
• Non-invasive, no contrast agents and has a scan time of
approximately 10 minutes.
• FerriScan provides an high sensitivity and specificity, accurate-
validated MRI-based measurement of liver iron concentration (LIC),
over the entire range encountered in clinical practice.
• Results are accurate, reliable and reproducible over time .
1. It is mandatory to ask about alcohol and iron over load in each hyperferritinemia
presentation.
2. Check the body mass index, blood pressure, blood sugar and blood lipid , if
suspecting metabolic syndrome.
3. Check the blood count and inflammatory markers (Creactive protein or erythrocyte
sedimentation rate) in order to detect occult inflammatory disorders.
4. Check serum creatinine and electrolytes for renal function
5. Check liver function tests: Abnormal results should prompt consideration of viral
hepatitis screening and abdominal ultrasonography.
6. Check the transferrin saturation: the level of transferrin saturation > 45% has a
sensitivity of 94% and a positive predictive value of 6% for hereditary
hemochromatosis (check for C282 Y homozygotes/H63D)
7. Refer the patient to Hematology and Hepatology if:
a. The patient has a confirmed iron overload with ferritin level of > 1000 μg/L
or abnormal liver function, regardless of the cause.
b. The patient has a positive HFE mutation results.
c. The patient has a high ferritin level need for frequent venesection
(Phlebotomy) or iron chelation; the aim is to lower the serum ferritin
concentrations to a level < 50 μg/L.
d. Check for genetic and iron overload in siblings of the hemochromatosis
patient.
e. Refer the patient for direct assessment of liver iron stores, for instance
Magnetic Resonance Imaging (MRI) or liver biopsy.
f. Refer the patient to Hepatology if viral hepatitis or inflammatory disorder
are suspected.
8. Consider interventions in patient
with metabolic Hyperferritinemia (SF
range 300-1000 μg/L), in whom iron
overload is unlikely (transferrin
saturation ≤ 45) by reducing SF
(alcohol abstinence, improved
glycemic control, weight reduction,
and lowering triglyceride
concentrations)
Hyperferritinemia with normal transferrin saturation, with or without iron
overload is often found in patients with hepatic steatosis and/or hepatitis.
The metabolic hyperferritinaemia (disorder of iron and glucose and/or lipid
metabolism) may occur with the incidence up to 49% in type 2 diabetes
mellitus.
1. https://link.springer.com/article/10.1007/s12185-017-2365-3.Gajendra Singh Dhakad, Ashish Kumar Sharma, Gulab Kanwar, Ajay Kumar
Singh4, Shrikant Sharma. Evaluation of iron profile in type 2 diabetes mellitus patients of tertiary care center of central India.
2. International Journal of Clinical Biochemistry and Research, January-March, 2019;6(1):15-19.The mechanisms of systemic iron
homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
3. Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis. Jasbir Makker,a,b,* Ahmad Hanif,b Bharat Bajantri,b and
Sridhar Chilimuria,b Metallomics. 2014 Apr;6(4):748-73. doi: 10.1039/c3mt00347g.
4. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Kell DB1, Pretorius E.
5. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. Paul C. Adams1, , James C. Barto
6. https://www.resonancehealth.com/products/ferriscan-mri-measurement-of-liver-iron-concentration.html
7. Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload. Robert Brudevold, Torstein Hole,
Jens Hammerstrøm.
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570219/.
9. https://www.em-consulte.com/en/article/1177870
10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807778/. The relationship between serum ferritin levels and electrocardiogram
characteristics in acutely ill patients.Krzysztof Laudanski, MD MA, Huma Ali, MD, Andrew Himmel, MD, Kasia Godula, MD, Mary
Stettmeier, MD, and Lisa Calvocoressi, PhD
Evaluation of Hyperferritinemia in Diabetic Patients

More Related Content

What's hot

What's hot (20)

Iron overload
Iron overload Iron overload
Iron overload
 
Hazeldine on Alcoholic Liver Disease
Hazeldine on Alcoholic Liver DiseaseHazeldine on Alcoholic Liver Disease
Hazeldine on Alcoholic Liver Disease
 
Nonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) ReviewNonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) Review
 
Understanding Liver Disease - Dr. Cecilia Minano - 9.19.18
Understanding Liver Disease - Dr. Cecilia Minano  - 9.19.18Understanding Liver Disease - Dr. Cecilia Minano  - 9.19.18
Understanding Liver Disease - Dr. Cecilia Minano - 9.19.18
 
Alcoholic hepatitis
Alcoholic hepatitisAlcoholic hepatitis
Alcoholic hepatitis
 
Secondary dyslipidemia
Secondary dyslipidemiaSecondary dyslipidemia
Secondary dyslipidemia
 
ALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASEALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASE
 
NAFLD
NAFLDNAFLD
NAFLD
 
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
 
Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)
 
Hyperuricemia and Gout
Hyperuricemia and GoutHyperuricemia and Gout
Hyperuricemia and Gout
 
Tumour induced osteomalacia
Tumour induced osteomalaciaTumour induced osteomalacia
Tumour induced osteomalacia
 
Aml m5 with plasmacytosis kirim
Aml m5 with plasmacytosis kirimAml m5 with plasmacytosis kirim
Aml m5 with plasmacytosis kirim
 
NAFLD, NASH
NAFLD, NASHNAFLD, NASH
NAFLD, NASH
 
Evidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseEvidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver disease
 
Secondary hyperparathyroidism
Secondary hyperparathyroidismSecondary hyperparathyroidism
Secondary hyperparathyroidism
 
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
 
Metabolic Associated Fatty Liver Disease (MAFLD) for General Practitioners of...
Metabolic Associated Fatty Liver Disease (MAFLD) for General Practitioners of...Metabolic Associated Fatty Liver Disease (MAFLD) for General Practitioners of...
Metabolic Associated Fatty Liver Disease (MAFLD) for General Practitioners of...
 
Alcoholic hepatitis
Alcoholic hepatitisAlcoholic hepatitis
Alcoholic hepatitis
 
NASH
NASHNASH
NASH
 

Similar to Evaluation of Hyperferritinemia in Diabetic Patients

Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
Sanjeev Kumar
 

Similar to Evaluation of Hyperferritinemia in Diabetic Patients (20)

Hemochromatosis presentation
Hemochromatosis presentationHemochromatosis presentation
Hemochromatosis presentation
 
Haemochromatosis
HaemochromatosisHaemochromatosis
Haemochromatosis
 
Hereditary Hemochromatosis
Hereditary HemochromatosisHereditary Hemochromatosis
Hereditary Hemochromatosis
 
Hemochromatosis1
Hemochromatosis1Hemochromatosis1
Hemochromatosis1
 
Inherited Liver Diseases.pptx
Inherited Liver Diseases.pptxInherited Liver Diseases.pptx
Inherited Liver Diseases.pptx
 
Inherited Liver Diseases.pptx
Inherited Liver Diseases.pptxInherited Liver Diseases.pptx
Inherited Liver Diseases.pptx
 
HEMOCHROMATOSIS.pptx
HEMOCHROMATOSIS.pptxHEMOCHROMATOSIS.pptx
HEMOCHROMATOSIS.pptx
 
Genetic haemochromatosis
Genetic haemochromatosisGenetic haemochromatosis
Genetic haemochromatosis
 
VIN 2013 - Warrillow on Acute Liver Failure
VIN 2013 - Warrillow on Acute Liver FailureVIN 2013 - Warrillow on Acute Liver Failure
VIN 2013 - Warrillow on Acute Liver Failure
 
ICN Victoria: Warrillow on Acute Liver Failure
ICN Victoria: Warrillow on Acute Liver FailureICN Victoria: Warrillow on Acute Liver Failure
ICN Victoria: Warrillow on Acute Liver Failure
 
Case presentation of primary hyperparathyroidism
Case presentation of primary hyperparathyroidismCase presentation of primary hyperparathyroidism
Case presentation of primary hyperparathyroidism
 
Approach to anaemia
Approach to anaemiaApproach to anaemia
Approach to anaemia
 
hereditary hemochromatosis
hereditary hemochromatosishereditary hemochromatosis
hereditary hemochromatosis
 
Non alcoholic steatohepatitis copy
Non alcoholic steatohepatitis   copyNon alcoholic steatohepatitis   copy
Non alcoholic steatohepatitis copy
 
Hyperferritinaemia
HyperferritinaemiaHyperferritinaemia
Hyperferritinaemia
 
Onco emergencies : DR. DEVAWRAT BUCHE
Onco emergencies : DR. DEVAWRAT BUCHEOnco emergencies : DR. DEVAWRAT BUCHE
Onco emergencies : DR. DEVAWRAT BUCHE
 
Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
 
liver.pptx
liver.pptxliver.pptx
liver.pptx
 
Liver transplant
Liver transplantLiver transplant
Liver transplant
 
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptxPARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
PARATHYROID GLANDS AND PATHOLOGY OF IT.pptx
 

More from hungnguyenthien

More from hungnguyenthien (20)

Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
Covid19 and Thyroid Gland, Dr Tran Ngan Chau et al, Medic Medical Center, HCM...
 
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
Report on LUS for post COVID19 Infection Patients, NGUYEN THIEN HUNG et al, M...
 
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
Lung Ultrasound Post-COVID-19 Infection, Hung Nguyen Thien and Ultrasound Dep...
 
LUNG ULTRASOUND for COVID-19
LUNG ULTRASOUND  for COVID-19LUNG ULTRASOUND  for COVID-19
LUNG ULTRASOUND for COVID-19
 
COVID-19
COVID-19COVID-19
COVID-19
 
H. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAIH. pylori update 2019[863] Dr VÕ THỊ CHI MAI
H. pylori update 2019[863] Dr VÕ THỊ CHI MAI
 
H pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAIH pylori clin virulence-diag aspects, Dr VO THI CHI MAI
H pylori clin virulence-diag aspects, Dr VO THI CHI MAI
 
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂNLAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
LAO CỘT SỐNG và SIÊU ÂM, Dr PHẠM THỊ THANH XUÂN
 
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTERABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
ABDOMINAL AORTIC ANEURYSM @ MEDIC CENTER
 
NECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUANNECK CYSTS, Dr PHAM THI THANH XUAN
NECK CYSTS, Dr PHAM THI THANH XUAN
 
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và csSWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
SWE-SSI and TS in Chronic Liver Disease, Ngô thị Huyền Trang và cs
 
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương GiangBIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
BIRADS- 5 NON CANCER, Dr Đỗ Bình Minh Dr Hương Giang
 
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
CAP va ARFI trong Gan Mỡ , Nguyễn Thiện Hùng, Nguyễn thị Hồng Anh , Phạm thị ...
 
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
Diffuse Large B Cell Lymphoma and Appearences in Oral Cavity, Maxillary and M...
 
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍMSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
MSI-H/DMMR SOLID CANCERS, Dr BÙI ĐẮC CHÍ
 
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh MinhTIRADs ACR  2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
TIRADs ACR 2017, Dr Kieu Trang- Dr Quynh Anh- Dr Binh Minh
 
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
 
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINHCase 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
Case 430: FACIAL EDEMA, Dr PHAN THANH HẢI, Dr LÊ NGỌC VINH
 
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢICase 422; TORSION of TESTIS, Dr PHAN THANH HẢI
Case 422; TORSION of TESTIS, Dr PHAN THANH HẢI
 
The two hit hypothesis, Dr BÙI ĐắC CHÍ
The two hit hypothesis, Dr BÙI ĐắC CHÍThe two hit hypothesis, Dr BÙI ĐắC CHÍ
The two hit hypothesis, Dr BÙI ĐắC CHÍ
 

Recently uploaded

Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
 
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
adilkhan87451
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
 

Recently uploaded (20)

Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur  Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Guntur  Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
 
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on WhatsappMost Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
 
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
Premium Call Girls In Jaipur {8445551418} ❤️VVIP SEEMA Call Girl in Jaipur Ra...
 
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
Russian Call Girls Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service...
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kakinada Just Call 9907093804 Top Class Call Girl Service Available
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
 

Evaluation of Hyperferritinemia in Diabetic Patients

  • 1.
  • 2. Ferritin=24 protein subunits capable of storing up to 4500 iron atoms. • Serum glycosylated ferritin: 60–80% (from macrophages) • Non-glycosylated ferritin: 20–40% (from cell lysis)
  • 3.
  • 4. • Serum ferritin: body iron stores, erythrocyte morphology. Hyperferritinemia can be a result of inflammation, infection, chronic iron overload, or other uncommon pathologies (hemophagocytic lymphohistiocytosis HLH) →Elevated serum ferritin concentrations are common in clinical practice, marker of cellular damage and inflammation (hydroxyl radical formation, oxidative stress), cell signaling and immune function, positively associated with insulin resistance and the metabolic syndrome, correlated strongly (r=0.49) with QT/QTs interval prolongation (longer than 450 ms). Hereditary hemochromatosis (HH) is the most common genetic iron overload disorder among Caucasians. • 1865: Dr. Armand Trousseau described diabetes with bronze-colored skin. • 1996: Feder et al. identified responsible gene named HFE (chromosomal location: 6p21). • After the discovery of HFE, researchers discovered several other gene mutations that also cause different types of HH. • Symptoms of iron overload: fatigue, bronze-colored skin, abdominal pain, joint pain, irregular menstruation, infertility, impotence, irregular heart rhythm, heart failure, new-onset diabetes, difficulty controlling established diabetes, liver enzyme elevation, cirrhosis, hepatocellular carcinoma, neurodegenerative disorders (Alzheimer, Parkinson, and Huntington diseases). • The central regulator of systemic iron homeostasis is hepcidin, a peptide hormone mainly produced by hepatocytes.
  • 5.
  • 6. Increased apoferritin/L ferritin synthesis/secretion: • Chronic ethanol ingestion • Malignancy (malignant histiocytosis; carcinomas of lung, breast, ovary, kidney lymphoma; liposarcoma) • Gaucher disease • Reactive histiocytosis. • Hereditary hyperferritinemia- cataract syndrome. Increased ferritin release from injured cells: • Hepatic steatosis and steatohepatitis • Metabolic syndrome (obesity, type 2 diabetes, dyslipidemia, hypertension) • Chronic viral hepatitis • Massive liver necrosis due to sepsis/acute hepatitis/ toxic injury/ autoimmune disorders • Acute or chronic infection/inflammation • Acute myocardial infarction • Splenic infarct Increased ferritin synthesis due to iron overload: • HFE and other types of hemochromatosis • Heritable & acquired anemias associated with ineffective erythropoiesis • Increased iron absorption from supplemental iron / traditional beer • transfusion iron overload • Aceruloplasminemia Renal failure More than 40% of patients with hyperferritinemia have several causes simultaneously present.
  • 7. • Genetic Iron Overload: 6 types: • (1) Type 1 hemochromatosis – HFE hemochromatosis. • (2) Type 2 hemochromatosis – juvenile hemochromatosis: (a) type 2A – mutation in hemojuvelin gene; (b) type 2B – mutation in hepcidin gene. • (3) Type 3 hemochromatosis – transferrin receptor 2 hemochromatosis. • (4) Type 4 hemochromatosis – ferroportin disease: (a) type 4A – with low transferrin saturation; (b) type 4B – with high transferrin saturation. • (5) A(hypo)transferrinemia. • (6) Aceruloplasminemia. • Acquired Iron Overload: • (1) Iatrogenic: (a) multiple blood transfusions; (b) parenteral iron therapy; (c) oral iron therapy. • (2) Chronic liver disease: (a) alcoholic liver disease; (b) hepatitis B and C; (c) porphyria cutanea tarda. • (3) Anemias: (a) thalassemia major; (b) chronic hemolytic anemia; (c) pyruvate kinase deficiency. • (4)
  • 8. • Male 22 years old • BMI=24 • BP= 112/77 mmHg, HR=75 bpm • Lose 3kg/2 months • No smoking, no alcohol abuse. • Family history : nothing abnormal
  • 9. .
  • 10. • Objectives: evaluate serum Ferritin in diabetic patients to estimate prognosis, glucose control ability • Methods: Descriptive cross-section statistics • Test: CBC, FBS, HbA1C, LDLC-C, TG, AST, ALT, GGT, eGFR, Urinalysis, microalbuminuria, uric acid, HBsAg, AntiHBs, AntiHBctotal, AntiHCV, FT4, TSH, Ferritin, serum iron, Transferin saturation, hsCRP, serum ionogram, Antinuclear Antibody (ANA) • Assess body mass index, blood pressure, liver steatosis (CAP: dB/m), liver fibrosis (Elastography: kPa) (Fibroscan 502TOUCHE F60084), B mode transabdominal US (Operators: Bùi Hồng Lĩnh et al.). • Inclusive criteria: • DM patients > 17 yrs and euthyroid. • Exclusive criteria • Haematologic diseases: thalassemia, chronic hemolytic anemia, sickle cell diseases & myelodysplastic syndrome . • Consumption beer / alcohol >20g/day • HBV, HCV • Malignancy. • Drug induced hepatitis • Autoimmune hepatitis • Pregnancy, breast-feeding period. • Iron supplement.
  • 11. Staging liver steatosis and fibrosis • Steatosis severity: CAP: dB/m • S0 = no steatosis • S1 =normal steatosis • S2 = mild steatosis • S3 = moderate steatosis • S4 = severe steatosis • Stages of liver fibrosis: kPa • F0 = no fibrosis • F1 = mild fibrosis • F2 = moderate fibrosis • F3 = much fibrosis • F4 = severe fibrosis
  • 12.
  • 13.
  • 14. Classification (Asian) BMI ( kilogram/m 2 ) Results (patients) % Underweight <18.5 5 1.86 Normal weight 18.5-24.9 150 55.97 Overweight 25-29.9 92 34.32 Obesity Class 1 30-34.9 19 7.08 Obesity Class 2 35-39.9 2 0.74 Extreme Obesity Class 3 >40 0 0 268 Hepatitis Non-hepatitis Total Hyperferritinemia 101 22 133 Normal ferritinemia 76 69 145 177 91 268
  • 15. Liver fibrosis & steatosis S1 S2 S3 S4 Total F0 52 14 12 7 85 F1 31 14 16 27 88 F2 18 4 3 11 36 F3 6 3 8 15 32 F4 11 4 5 7 27 Total 118 39 44 67 268
  • 16. ESTIMATE OF HYPERFERRITINEMIA№ patients № patients of hyperferritinemia % patients of hyperferrtinemia F0 85 41 48,23 % F1 88 45 51,13 % F2 36 21 58,33 % F3 32 15 46,57 % F4 27 11 40,74 % Total 268 133 49,62 % № patients № patients of hyperferritinemia % patients of hyperferritinemia S1 118 49 41.52 % S2 39 18 46.15% S3 44 26 59.09% S4 67 40 59.70% Total 268 133 49,62 %
  • 17. • Sept 2018 - April 2019. • 268 type 2 diabetic patients (119 M, 149F). • Age=17 - 87 years . • Duration of acquired DM= first onset - 23years. • 21 obese patients (7.82%) + 92 overweight patients (34.32%) = 42.14% • Hypertension: 152 patients (56,71%). • Kidney disease: 87 patients (32.46%).. • Dyslipidemia: 247 patients (92,16%). • Liver steatosis: 150 patients (55.97%) • Significant liver fibrosis (≥ F2: 35.45%)
  • 18. • Hyperferritinemia: 133 patients (49,62%), no significant difference between liver fibrosis degree. • Young onset <40y: 38 patients (10.1%): 19 patients had hyperferritinemia (50%) → No difference in frequency of hyperferritinemia between ages. • Male hyperferritinemia:73 patients (73/119=61.3% male), Female hyperferritinemia: 60 patients (60/149=40.2% female) → • Moderate & severe liver steatosis link to higher rate of hyperferritinemia (59% vs 41%). • Hepatitis: 177 patients (66%); 101 hyperferritinemia hepatitic patients (57.06%) No hepatitis: 91 patients (33.95%); 22 hyperferrtinemia patients (24.17%) → • Severe hyperferritinemia (Ferritinemia > 1000ng/mL: 18 cases)+ extreme hyperferritnemia (Ferritinemia > 2000ng/mL: 4cases): 16.54% of hyperferritinemia
  • 20. Discussion • Dysmetabolic hyperferritinemia, being more prevalent especially in the presence of metabolic syndrome, should be considered as the most likely disorder in such scenarios of high ferritin with normal transferrin saturation. • There are many types of hyperferritinemia presented in primary care.“ which are more prevalent in the Gulf countries states, reaching up Arab 29% to 33% in males, and 38% to 41% in females respectively. • This study: • Mild elevations of SF < 1000 μg/L are tolerable levels in the absence of HH; the risk of hepatic iron overload is exceedingly low, whereas high elevation of SF > 1000μg/L requires specialist review to rule out HH with an increased risk of hepatic iron overload, which leads to hepatic fibrosis and cirrhosis.
  • 21. • International regulatory clearance and approvals (USA, Europe, Australia) • The technique is robust, there is no shift in accuracy or precision across different MRI scanners, between MRI centres and models of scanner. • FerriScan is unaffected by inflammation, fibrosis, cirrhosis or chelation therapy. • FerriScan requires no breath-hold and may therefore be used for paediatric patients, patients of all ages. • Non-invasive, no contrast agents and has a scan time of approximately 10 minutes. • FerriScan provides an high sensitivity and specificity, accurate- validated MRI-based measurement of liver iron concentration (LIC), over the entire range encountered in clinical practice. • Results are accurate, reliable and reproducible over time .
  • 22. 1. It is mandatory to ask about alcohol and iron over load in each hyperferritinemia presentation. 2. Check the body mass index, blood pressure, blood sugar and blood lipid , if suspecting metabolic syndrome. 3. Check the blood count and inflammatory markers (Creactive protein or erythrocyte sedimentation rate) in order to detect occult inflammatory disorders. 4. Check serum creatinine and electrolytes for renal function 5. Check liver function tests: Abnormal results should prompt consideration of viral hepatitis screening and abdominal ultrasonography. 6. Check the transferrin saturation: the level of transferrin saturation > 45% has a sensitivity of 94% and a positive predictive value of 6% for hereditary hemochromatosis (check for C282 Y homozygotes/H63D)
  • 23. 7. Refer the patient to Hematology and Hepatology if: a. The patient has a confirmed iron overload with ferritin level of > 1000 μg/L or abnormal liver function, regardless of the cause. b. The patient has a positive HFE mutation results. c. The patient has a high ferritin level need for frequent venesection (Phlebotomy) or iron chelation; the aim is to lower the serum ferritin concentrations to a level < 50 μg/L. d. Check for genetic and iron overload in siblings of the hemochromatosis patient. e. Refer the patient for direct assessment of liver iron stores, for instance Magnetic Resonance Imaging (MRI) or liver biopsy. f. Refer the patient to Hepatology if viral hepatitis or inflammatory disorder are suspected.
  • 24. 8. Consider interventions in patient with metabolic Hyperferritinemia (SF range 300-1000 μg/L), in whom iron overload is unlikely (transferrin saturation ≤ 45) by reducing SF (alcohol abstinence, improved glycemic control, weight reduction, and lowering triglyceride concentrations)
  • 25. Hyperferritinemia with normal transferrin saturation, with or without iron overload is often found in patients with hepatic steatosis and/or hepatitis. The metabolic hyperferritinaemia (disorder of iron and glucose and/or lipid metabolism) may occur with the incidence up to 49% in type 2 diabetes mellitus.
  • 26. 1. https://link.springer.com/article/10.1007/s12185-017-2365-3.Gajendra Singh Dhakad, Ashish Kumar Sharma, Gulab Kanwar, Ajay Kumar Singh4, Shrikant Sharma. Evaluation of iron profile in type 2 diabetes mellitus patients of tertiary care center of central India. 2. International Journal of Clinical Biochemistry and Research, January-March, 2019;6(1):15-19.The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. 3. Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis. Jasbir Makker,a,b,* Ahmad Hanif,b Bharat Bajantri,b and Sridhar Chilimuria,b Metallomics. 2014 Apr;6(4):748-73. doi: 10.1039/c3mt00347g. 4. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Kell DB1, Pretorius E. 5. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. Paul C. Adams1, , James C. Barto 6. https://www.resonancehealth.com/products/ferriscan-mri-measurement-of-liver-iron-concentration.html 7. Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload. Robert Brudevold, Torstein Hole, Jens Hammerstrøm. 8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570219/. 9. https://www.em-consulte.com/en/article/1177870 10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807778/. The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients.Krzysztof Laudanski, MD MA, Huma Ali, MD, Andrew Himmel, MD, Kasia Godula, MD, Mary Stettmeier, MD, and Lisa Calvocoressi, PhD

Editor's Notes

  1. .